![](/img/cover-not-exists.png)
PCN10 A MATCH-ADJUSTED INDIRECT TREATMENT COMPARISON (MAIC) OF LENALIDOMIDE PLUS RITUXIMAB (R2) VERSUS RITUXIMAB PLUS CHEMOTHERAPY (R-CHEMO) FOR RELAPSED AND/OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)
Fox, C., Arcaini, L., Hernandez-Ilizaliturri, F., Tabah, A., Parker, C., Jones, J., Abouzaid, S., Watkins, C.L., Bachy, E.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.207
Date:
November, 2019
File:
PDF, 649 KB
2019